
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
How to watch the 2025 Macy's Thanksgiving Day Parade for free - 2
Phonetic Associations: A Survey of \Interfacing Worldwide People group\ Language Trade Application - 3
Virtual reality opens doors for older people to build closer connections in real life - 4
Black Friday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60% - 5
Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s
How does Spotify Wrapped calculate your listening age? What your number says about you.
Let them eat (Taylor Swift) cake: The baker turning A-listers into life-size desserts
Americans generally like wolves − except when we’re reminded of our politics
Virtual Domains d: A Survey of \Inundation and Ongoing interaction Mechanics\ Computer game
Figure out How to Keep up with Oral Wellbeing During Pregnancy
As tetanus vaccination rates decline, doctors worry about rising case numbers
Figure out How to Assess the Unwavering quality of SUVs for Seniors
4 injured in suburban Philadelphia nursing home explosion file negligence lawsuit












